108 Episoder

  1. Radiotherapy induced neurocognitive decline

    Publisert: 24.10.2025

  2. QOL and cognitive functioning in patients with oligodendroglioma

    Publisert: 26.9.2025

  3. Post-operative radiation in recurrent grade 1 meningiomas

    Publisert: 12.9.2025

  4. mRNA CAR T against GD2 in high-grade glioma models

    Publisert: 29.8.2025

  5. A transcriptomic atlas of CNS tumors

    Publisert: 11.7.2025

  6. Gut microbiome in primary CNS lymphoma

    Publisert: 27.6.2025

  7. Germline analysis of diffuse midline glioma

    Publisert: 8.6.2025

  8. The proteomic landscape of diffuse midline glioma

    Publisert: 17.5.2025

  9. Radio-Pathomic maps and MR perfusion

    Publisert: 18.4.2025

  10. CSF proteomics in glioma

    Publisert: 21.3.2025

  11. Vorasidenib in IDH mutant glioma

    Publisert: 8.3.2025

  12. KL-50 in post TMZ MMR-deficient GBM

    Publisert: 22.2.2025

  13. Measurable disease per FET-PET vs MRI in GBM

    Publisert: 8.2.2025

  14. Pre-radiation chemotherapy in GBM

    Publisert: 20.1.2025

  15. cIMPACT-NOW Update 8: grading of meningiomas

    Publisert: 13.12.2024

  16. Residual tumor volume and survival after CCNU/TMZ in GBM

    Publisert: 24.11.2024

  17. Alterations in RNA splicing between meningioma DNA methylation groups

    Publisert: 8.11.2024

  18. The immune landscape of IDH mutant and IDHwt glioma

    Publisert: 25.10.2024

  19. Equity-driven applications of AI in neuro-oncology

    Publisert: 9.10.2024

  20. IDH mutant glioma across age groups

    Publisert: 20.9.2024

1 / 6

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site